Literature DB >> 18791276

Low rates of aneuploidy promote tumorigenesis while high rates of aneuploidy cause cell death and tumor suppression.

Beth A A Weaver, Alain D Silk, Don W Cleveland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18791276      PMCID： PMC4618964          DOI： 10.3233/clo-2008-0445

Source DB:  PubMed          Journal:  Cell Oncol        ISSN： 1570-5870            Impact factor:   6.730


× No keyword cloud information.
  10 in total

Review 1.  Mitotic DNA Damage Response: At the Crossroads of Structural and Numerical Cancer Chromosome Instabilities.

Authors:  Samuel F Bakhoum; Lilian Kabeche; Duane A Compton; Simon N Powell; Holger Bastians
Journal:  Trends Cancer       Date:  2017-02-28

Review 2.  Cell cycle kinases as therapeutic targets for cancer.

Authors:  Silvia Lapenna; Antonio Giordano
Journal:  Nat Rev Drug Discov       Date:  2009-07       Impact factor: 84.694

3.  Haploinsufficiency of SGO1 results in deregulated centrosome dynamics, enhanced chromosomal instability and colon tumorigenesis.

Authors:  Hiroshi Y Yamada; Yixin Yao; Xiaoxing Wang; Yuting Zhang; Ying Huang; Wei Dai; Chinthalapally V Rao
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

4.  A novel microtubule-modulating noscapinoid triggers apoptosis by inducing spindle multipolarity via centrosome amplification and declustering.

Authors:  P Karna; P C G Rida; V Pannu; K K Gupta; W B Dalton; H Joshi; V W Yang; J Zhou; R Aneja
Journal:  Cell Death Differ       Date:  2010-11-05       Impact factor: 15.828

Review 5.  Chromosomal instability and cancer: a complex relationship with therapeutic potential.

Authors:  Samuel F Bakhoum; Duane A Compton
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

6.  Mitotic Stress and Chromosomal Instability in Cancer: The Case for TPX2.

Authors:  Ignacio Pérez de Castro; Marcos Malumbres
Journal:  Genes Cancer       Date:  2012-11

Review 7.  Targeting karyotypic complexity and chromosomal instability of cancer cells.

Authors:  Anna V Roschke; Ilan R Kirsch
Journal:  Curr Drug Targets       Date:  2010-10       Impact factor: 3.465

8.  Silencing of E2F3 suppresses tumor growth of Her2+ breast cancer cells by restricting mitosis.

Authors:  Miyoung Lee; Gabriela Oprea-Ilies; Harold I Saavedra
Journal:  Oncotarget       Date:  2015-11-10

9.  The Nek2 centrosome-mitotic kinase contributes to the mesenchymal state, cell invasion, and migration of triple-negative breast cancer cells.

Authors:  Yainyrette Rivera-Rivera; Mihaela Marina; Shirley Jusino; Miyoung Lee; Jaleisha Vélez Velázquez; Camille Chardón-Colón; Geraldine Vargas; Jaya Padmanabhan; Srikumar P Chellappan; Harold I Saavedra
Journal:  Sci Rep       Date:  2021-04-27       Impact factor: 4.379

10.  Centrosome aberrations and chromosome instability contribute to tumorigenesis and intra-tumor heterogeneity.

Authors:  Shirley Jusino; Fabiola M Fernández-Padín; Harold I Saavedra
Journal:  J Cancer Metastasis Treat       Date:  2018-08-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.